#United States #New York #Class Action #Gross Law Firm #Replimune Group

Replimune Group, Inc. Class Action Lawsuit Alert

The Gross Law Firm has issued an important notice for investors of Replimune Group, Inc. (NASDAQ: REPL) regarding a class action lawsuit. Shareholders who acquired shares of Replimune during the designated class period, which spans from November 22, 2024, to July 21, 2025, are encouraged to reach out to the firm for potential lead plaintiff appointment. Being designated as a lead plaintiff is not a prerequisite for participating in the recovery process.

Key Details for Investors

Recent allegations indicate that Replimune was involved in issuing materially false or misleading statements. The primary complaint centers on the IGNYTE trial, where it is claimed that the defendants overstated its prospects, despite being aware of significant issues. Consequently, the FDA determined that the IGNYTE trial was inadequate, which raises concerns regarding the basis of Replimune's operational and financial statements during this period.

Class Period and Allegations

The designated class period commences on November 22, 2024, and concludes on July 21, 2025. During this interval, the gross complaints allege that Replimune's leadership failed to disclose critical information regarding the trial's effectiveness, leading to inflated investor expectations and ultimately severe financial repercussions when the truth emerged. This violation casts a shadow over the company's credibility and has left many investors seeking answers and potential compensation.

Deadlines and Next Steps

Investors are specifically cautioned about the upcoming deadline of September 22, 2025, set for those who wish to register for the class action lawsuit. This deadline is crucial for shareholders who want to ensure their voices are heard and potentially join their peers in reclaiming losses sustained during the misleading disclosures.

Once registered, shareholders will be enrolled in a portfolio monitoring software designed to keep them updated throughout the legal proceedings. Importantly, joining the class action does not involve any financial obligation or cost, making it an accessible option for harmed investors.

About The Gross Law Firm

The Gross Law Firm is nationally recognized for its commitment to protecting the rights of investors. Their mission centers around seeking justice for shareholders who have faced losses due to unscrupulous business practices and deceitful conduct by corporations. 🚀 Their reputation underscores a dedication to accountability and responsible corporate behavior, aiming for transparency in corporate reporting.

For those who purchased shares of Replimune Group within the relevant timeframe and wish to seek further details or engage with a potential class action, direct communication with The Gross Law Firm’s representatives is encouraged via the provided channels.

Contact Information

To register or obtain more information about the lawsuit:

• - Visit: Gross Law Firm
• - Email: [email protected]
• - Phone: (646) 453-8903

Investors are urged not to delay in taking action, as the clock is ticking towards significant deadlines that could impact their chances for recovery. Engage now to ensure your voice is heard in this pivotal case!